Heron Therapeutics, Inc. v. Fresenius Kabi USA, LLC et al
| Heron Therapeutics, Inc. |
| Fresenius Kabi USA, LLC and Fresenius Kabi AG |
| 1:2022cv00985 |
| July 27, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 21, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 WAIVER OF SERVICE returned executed by Heron Therapeutics, Inc.: For Fresenius Kabi AG waiver sent on 8/4/2022, answer due 10/3/2022. (Tigan, Jeremy) |
| Filing 8 WAIVER OF SERVICE returned executed by Heron Therapeutics, Inc.: For Fresenius Kabi USA, LLC waiver sent on 8/4/2022, answer due 10/3/2022. (Tigan, Jeremy) |
| Pro Hac Vice Attorney Mark Russell Sperling, Bruce M. Wexler, Christopher P. Hill, and Isaac S. Ashkenazi for Heron Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling filed by Heron Therapeutics, Inc. Signed by Judge Colm F. Connolly on 8/8/2022. (nmf)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling - filed by Heron Therapeutics, Inc.. (Tigan, Jeremy) |
| Filing 6 Summons Issued as to Fresenius Kabi AG on 7/28/2022; Fresenius Kabi USA, LLC on 7/28/2022. (Attachments: #1 Summons Issued Fresenius Kabi AG)(smg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Heron Therapeutics, Inc. (smg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (smg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about June 14, 2022. Date of Expiration of Patent: September 18, 2035.Thirty Month Stay Deadline: On or about 12/14/2024. (smg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Filing 1 COMPLAINT for Patent Infringement - filed against Fresenius Kabi AG, Fresenius Kabi USA, LLC ( Filing fee $ 402, receipt number ADEDC-3924170.) - filed by Heron Therapeutics, Inc. (Attachments: #1 Exhibit A-I, #2 Civil Cover Sheet)(smg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
